SUSAN BLANEY to Medical Oncology
This is a "connection" page, showing publications SUSAN BLANEY has written about Medical Oncology.
Connection Strength
1.264
-
Editorial: Recent advances in pediatric oncology. Curr Opin Pediatr. 2019 02; 31(1):1-2.
Score: 0.565
-
Recent advances in pediatric oncology. Curr Opin Pediatr. 2018 02; 30(1):1-2.
Score: 0.527
-
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group. Eur J Cancer. 2012 Mar; 48(4):579-85.
Score: 0.086
-
New approaches to drug development in pediatric oncology. Cancer J. 2005 Jul-Aug; 11(4):324-30.
Score: 0.055
-
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group. J Clin Oncol. 2007 Apr 20; 25(12):1505-11.
Score: 0.016
-
Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2007 Apr 20; 25(12):1512-8.
Score: 0.016